ADC Therapeutics News

Company Name Stock Ticker Symbol Market Type
ADC Therapeutics SA ADCT NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.54 -15.84% 2.87 16:06:05
Open Price Low Price High Price Close Price Prev Close
3.38 2.75 3.38 2.87 3.41
more quote information »

Recent News

Date Time Source Heading
12/07/20228:55IHNWFeaturedWorldwide Crypto Based Exchange Traded Products AUM Dropped 17% in November
11/28/202221:13BWBiocytogen conclut un accord sur les anticorps avec ADC..
11/28/202215:05BWBiocytogen schließt Antikörper-Vereinbarung mit ADC..
11/28/202209:47BWBiocytogen Enters into Antibody Agreement with ADC..
11/14/202211:36TRMNMorgan Stanley Sticks to Their Hold Rating for ADC..
11/09/202216:49BWADC Therapeutics publie ses résultats financiers du..
11/09/202202:08BWADC Therapeutics meldet Finanzergebnisse für das dritte..
11/08/202207:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/08/202207:00BWADC Therapeutics Reports Third Quarter 2022 Financial..
11/07/202215:45BWADC Therapeutics prendra part à la Jefferies London..
11/07/202207:15BWADC Therapeutics to Participate in the Jefferies London..
11/03/202216:04BWADC Therapeutics annonce les résumés acceptés pour être..
11/03/202215:17BWADC Therapeutics gibt die Annahme der Abstracts zur..
11/03/202209:34BWADC Therapeutics Announces Abstracts Accepted for..
11/03/202206:22BWIGM Biosciences und ADC Therapeutics geben klinische..
11/03/202202:57BWIGM Biosciences et ADC Therapeutics annoncent un accord de..
11/02/202217:28EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/02/202216:05BWIGM Biosciences and ADC Therapeutics Announce Clinical..
11/01/202217:04BWADC Therapeutics ernennt Kristen Harrington-Smith zum Chief..
11/01/202207:22EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/01/202207:15BWADC Therapeutics Appoints Kristen Harrington-Smith as Chief..
10/31/202214:32BWADC Therapeutics tiendra le 8 novembre 2022 une..
10/31/202207:15BWADC Therapeutics to Host Third Quarter 2022 Financial..
9/22/202209:05TRMNH.C. Wainwright Keeps Their Buy Rating on ADC Therapeutics..
9/22/202208:13BWADC Therapeutics annonce la présentation de résumés à..
9/22/202206:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/22/202201:56BWADC Therapeutics kündigt Abstracts an, die auf der 10...
9/21/202219:00BWADC Therapeutics Announces Abstracts to be Presented at the..
9/19/202206:02EDGARNotice of Effectiveness (effect)
9/19/202206:02EDGARNotice of Effectiveness (effect)
9/16/202217:01EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
9/16/202216:53BWADC Therapeutics und Sobi melden positive CHMP-Stellungnahme..
9/16/202216:19BWADC Therapeutics et Sobi annoncent que ZYNLONTA®..
9/16/202208:26DJNADC Therapeutics, Swedish Orphan Biovitrum's Co-Developed..
9/16/202207:24EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/16/202207:15BWADC Therapeutics and Sobi Announce ZYNLONTA® (loncastuximab..
9/07/202209:35EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/06/202216:42EDGARSecurities Registration (foreign Private Issuer) (f-3)
9/06/202216:32EDGARSecurities Registration (foreign Private Issuer) (f-3)
9/06/202215:14BWADC Therapeutics nimmt an Morgan Stanley 20. Annual Global..
9/06/202210:14BWADC Therapeutics participera à la 20e Conférence annuelle..
9/06/202207:15BWADC Therapeutics to Participate in Morgan Stanley’s 20th..
8/16/202209:04EDGARPost-effective Amendment to Registration Statement (pos Am)
8/16/202201:43BWADC Therapeutics annonce l'octroi d'un prêt à terme garanti..
8/15/202217:18EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/15/202216:30BWADC Therapeutics Announces $175 million Senior Secured Term..
8/10/202208:36TRMNADC Therapeutics (ADCT) Receives a Buy from RBC Capital
8/10/202208:33BWADC Therapeutics meldet Finanzergebnisse für das zweite..
8/10/202208:26BWADC Therapeutics publie ses résultats financiers du deuxième..
8/09/202207:24EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/09/202207:00BWADC Therapeutics Reports Second Quarter 2022 Financial..